(A) Schematic representation of the constructs used. WDN is a dominant-negative of Wnt9A, deleted for the C-terminal cysteine-rich domain. CDN is a dominant-negative of Nr2f1 (also known as COUP-TFI), with a point mutation in the DNA binding domain (orange). GDN is a dominant-negative of Gata6 in which the Gata6 DNA binding domain is fused to the engrailed (En) inhibitory transactivator domain. (B-D) Control embryos (8-cell stage) cultured for a day after single cell injection of RFP (red) at the 2-cell-stage. After co-injection with CDN (B) or Gata6 (C) mRNA, immunostaining of Nr2f1 (B) or Gata6 (C) is detectable in the nuclei of RFP-positive cells, as expected. Three- (B1-C1) or two- (B2-C2) channel merged pictures. Scale bar 50μm. β-catenin localisation (D) in uninjected, WDN and Wnt9a injected embryos (8-cell stage). (E) The ratio between nuclear and cytoplasmic β-catenin (n=8 cells) is significantly decreased and increased after WDN and Wnt9A injection respectively (T- test). (F-G) Cells were injected at the blastocyst stage with RFP mRNA only (control) or together with one of the constructs shown in (A). Analysis of the fate of surface (F) and deeper (G) injected ICM cells, as a percentage of daughter cells observed at the end of the track at the surface and in the deeper compartment respectively. (*) The fate of GDN injected cells (Fisher test) and that of gata+Wnt injected cells are highly significantly different from the control. The numbers of daughter cells analysed are: 60 (surface control), 13 (CDN), 33 (GDN), 7 (WDN), 29 (deep control), 33 (gata), 6 (Wnt), 44 (gata+Wnt).